Description
Why It’s Done:
The Leishmania Donovani LD Bodies Detection Test is typically performed to:
• Confirm diagnosis of visceral leishmaniasis (Kala-azar): This test is one of the definitive methods for diagnosing visceral leishmaniasis by detecting the parasite directly in tissue samples.
• Diagnose patients with symptoms of Kala-azar: Symptoms include fever, weight loss, enlargement of the spleen and liver (hepatosplenomegaly), anemia, and weakness. It is particularly useful when symptoms suggest the disease but other diagnostic methods have not confirmed it.
• Monitor treatment response: The test may be used to assess the effectiveness of treatment and determine whether the infection has been successfully cleared.
• Identify endemic areas or outbreaks: In areas where Leishmania donovani is endemic, this test is useful for confirming cases and guiding public health responses.
• Distinguish from other causes of similar symptoms, such as malaria or tuberculosis, which may have overlapping signs but require different treatments
Preparation:
• No fasting or special preparation is typically required for the test, but preparation may depend on the type of sample being collected.
• A clinical sample (usually bone marrow, spleen, liver, or lymph node aspirate) will be taken under sterile conditions. This may require local anesthesia and may be done using a needle aspiration procedure.
• Inform your healthcare provider if you have recently traveled to or lived in areas where Leishmania donovani infection is common (e.g., parts of India, Africa, and South America).


